Skip navigation links
Centers for Disease Control and Prevention
 CDC Home Search Health Topics A-Z
International Conference on Emerging Infectious Diseases
National Center for Infectious Diseases


ICEID 2002

 Webcast

Sunday

Monday

Tuesday

   Wednesday
   Plenary Sessions
   Invited Panels
   Slide Sessions
   Meet the Experts and First Encounters
   A-Z Listing by Speakers
   A-Z Listing by Presentation Title
   A-Z Listing by Major Topic
   A-Z Listing by Agent or Disease
 Continuing Education Credits
 Program
 Organizing Committee
 Partners

ICEID 2000

International Conference on Emerging Infectious Diseases
ICEID Home Contact Us

ICEID 2002 Webcast
Sessions by Day

Wednesday, March 27
Meet The Experts II
  • Behind the Scenes at the Emerging Infectious Disease Journal
    Peter Drotman, CDC, Atlanta, GA; Poly Potter, CDC, Atlanta, GA; Brian Mahy, CDC, Atlanta, GA
  • Prevention Effectiveness
    Martin Meltzer, CDC, Atlanta, GA; Anne Haddix, School of Public Health, Emory University, Atlanta, GA
Plenary Session V
  • Global Drug Resistance: The Case of Streptococcus pneumoniae
    Keith Klugman, School of Public Health, Emory University, Atlanta, GA
  • Use of Antiretroviral Agents in Developing Countries
    Peter Mugyenyi, Joint Clinical Research Center, Kampala, Uganda
Plenary Session VI
  • Genetic Susceptibility to Infectious Diseases
    Janet McNicholl, CDC, Atlanta, GA
  • Virology of 1918 Flu Pandemic
    Ann Reid, Armed Forces Institute of Pathology, Washington, DC
Panel Sessions 

Anatomy of Emerging Infectious Diseases

  • Impact of the BSE/vCJD Outbreak: U.S. Concerns for TSEs
    Ermias Belay, CDC, Atlanta, GA
  • The Agent: Prions as Emerging Infectious Particles
    David Bolton, New York State Institute for Basic Research, Staten Island, NY
  • The Reservoir: Bovine Spongiform Encephalopathy and What's Been Done About It
    Dagmar Heim, Swiss Federal Veterinary Office, Bern-Liebefeld, Switzerland
  • The Unfolding Variant (vCJD) Epidemic
    Robert Will, Western General Hospital, Edinburgh, United Kingdom

Antimicrobial Resistance

  • Computerized Decision Support for Appropriate Antimicrobial Drug Prescribing
    Matthew Samore, University of Utah, Salt Lake City, UT
  • Implications of Gene Transfer and Inducible Resistance for Successful Therapy
    Abigail Salyers, American Society for Microbiology, Washington, DC
  • Promoting Appropriate Antimicrobial Drug Use in Developing Countries
    Sayomporn Sirinavin, Mahidol University, Bangkok, Thailand
  • Prospects for New Antimicrobial Drug Development: Industry Perspective
    Gail Cassell, Eli Lilly and Company, Indianapolis, IN

Emerging Vaccines for Emerging Diseases

  • Anthrax Vaccines
    Arthur Friedlander, U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD
  • Group B Meningococcal Vaccines
    Gustavo Sierra, Finlay Institute, Havana, Cuba
  • New Technologies and Vaccine Development
    Margaret Ann Liu, Bill and Melinda Gates Foundation, Seattle, WA
  • Rotavirus Vaccines in Development
    Rajiv Bahn, All India Institute of Medical Sciences, New Delhi, India

Foreign Policy and Infectious Disease

  • Emerging Infectious Diseases: The World Bank Perspective
    O.K. Pannenborg, The World Bank, Washington, DC
  • Global Fund to Fight HIV/AIDS, TB, and Malaria (New Political/Economic Model for Addressing Priority Infectious Diseases)
    Bill Steiger, U.S. Department of Health and Human Services, Washington DC

Infectious Diseases in Aging Populations

  • Biology of Aging
    Steven Castle, University of California at Los Angeles, Los Angeles, CA
  • Biology of Immune Senescence
    Richard Miller, University of Michigan, Ann Arbor, MI
  • HIV in the Older Patient
    Bradley Bender, University of Florida, Gainesville, FL
  • Impact of Aging on the Epidemiology of Infections in Adults
    Thomas Yoshikawa, Charles R. Drew University of Medicine and Science, Los Angeles, CA

Top of Page

  Top of Page

 

ICEID Home | Contact Us

CDC Home | Search | Health Topics A-Z

This page last reviewed April 17, 2002

International Conference on Emerging Infectious Diseases
National Center for Infectious Diseases
Centers for Disease Control and Prevention

Privacy Policy | Accessibility
 

 U.S. Department of Health and Human Services (HHS)